Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boland

Showing results (431-440 of 571) with videos related to

Pageof 58
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2011
Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISHEunhee S Yi, Jennifer M Boland, Joseph J Maleszewski, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
A synthetic peptide, derived from neurotoxin GsMTx4, acts as a non-opioid analgesic to alleviate mechanical and neuropathic pain through the TRPV4 channelShaoXi Ke, Ping Dong, Yi Mei, et al.
Frontiers in Immunology|June 30, 2023
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapyChad Pickering, Paul Aiyetan, Gege Xu, et al.
Genomics, Proteomics & Bioinformatics|May 16, 2020
CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant MelanomaZiyi Li, Binbin Wang, Shengqing Gu, et al.
Journal of the American Academy of Dermatology|February 22, 2022
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanomaMaria S Asdourian, Tracey S Otto, Ted V Jacoby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2011
Worse disease-free survival in never-smokers with ALK+ lung adenocarcinomaPing Yang, Kimary Kulig, Jennifer M Boland, et al.
Archives of Pathology & Laboratory Medicine|August 4, 2025
A Prospective Video-Reflexive Ethnographic Study of Direct Patient-Pathologist Interactions With Heart and Lung Allograft RecipientsAnja C Roden, Gladys B Asiedu, Angela K Regnier, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Overcoming impaired antigen presentation in tumor draining lymph nodes facilitates immunotherapyMeghan J O'Melia, Lutz Menzel, Pin-Ji Lei, et al.
JCO Precision Oncology|January 18, 2024
Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal MelanomaTakuto Sato, Kamaneh Montazeri, Evangelos S Gragoudas, et al.
American Journal of Clinical Pathology|May 21, 2019
Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse SitesAqsa Nasir, Heidi D Lehrke, Taofic Mounajjed, et al.
Pageof 58

Showing results (431-440 of 571) with videos related to

Sort By:
Pageof 58
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2011
Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISHEunhee S Yi, Jennifer M Boland, Joseph J Maleszewski, et al.
Acta Pharmaceutica Sinica. B|May 15, 2025
A synthetic peptide, derived from neurotoxin GsMTx4, acts as a non-opioid analgesic to alleviate mechanical and neuropathic pain through the TRPV4 channelShaoXi Ke, Ping Dong, Yi Mei, et al.
Frontiers in Immunology|June 30, 2023
Plasma glycoproteomic biomarkers identify metastatic melanoma patients with reduced clinical benefit from immune checkpoint inhibitor therapyChad Pickering, Paul Aiyetan, Gege Xu, et al.
Genomics, Proteomics & Bioinformatics|May 16, 2020
CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant MelanomaZiyi Li, Binbin Wang, Shengqing Gu, et al.
Journal of the American Academy of Dermatology|February 22, 2022
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanomaMaria S Asdourian, Tracey S Otto, Ted V Jacoby, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 3, 2011
Worse disease-free survival in never-smokers with ALK+ lung adenocarcinomaPing Yang, Kimary Kulig, Jennifer M Boland, et al.
Archives of Pathology & Laboratory Medicine|August 4, 2025
A Prospective Video-Reflexive Ethnographic Study of Direct Patient-Pathologist Interactions With Heart and Lung Allograft RecipientsAnja C Roden, Gladys B Asiedu, Angela K Regnier, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Overcoming impaired antigen presentation in tumor draining lymph nodes facilitates immunotherapyMeghan J O'Melia, Lutz Menzel, Pin-Ji Lei, et al.
JCO Precision Oncology|January 18, 2024
Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal MelanomaTakuto Sato, Kamaneh Montazeri, Evangelos S Gragoudas, et al.
American Journal of Clinical Pathology|May 21, 2019
Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse SitesAqsa Nasir, Heidi D Lehrke, Taofic Mounajjed, et al.
Pageof 58